BRKR Bruker Corp

Price (delayed)

$93.94

Market cap

$12.93B

P/E Ratio

32.17

Dividend/share

$0.2

EPS

$2.92

Enterprise value

$13.8B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's EPS is up by 46% year-on-year and by 35% since the previous quarter
The net income is up by 44% year-on-year and by 34% since the previous quarter
The quick ratio has decreased by 33% YoY but it has increased by 13% from the previous quarter
BRKR's price to earnings (P/E) is 15% lower than its 5-year quarterly average of 37.6 but 2.7% higher than its last 4 quarters average of 31.3
Bruker's debt has increased by 11% from the previous quarter and by 8% YoY

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
137.67M
Market cap
$12.93B
Enterprise value
$13.8B
Valuations
Price to book (P/B)
9.44
Price to sales (P/S)
4.64
EV/EBIT
25.33
EV/EBITDA
20.92
EV/Sales
4.66
Earnings
Revenue
$2.96B
EBIT
$544.9M
EBITDA
$659.8M
Free cash flow
$254.3M
Per share
EPS
$2.92
Free cash flow per share
$1.74
Book value per share
$9.95
Revenue per share
$20.25
TBVPS
$22.79
Balance sheet
Total assets
$4.25B
Total liabilities
$2.84B
Debt
$1.36B
Equity
$1.38B
Working capital
$962.1M
Liquidity
Debt to equity
0.98
Current ratio
1.8
Quick ratio
0.89
Net debt/EBITDA
1.32
Margins
EBITDA margin
22.3%
Gross margin
51%
Net margin
14.4%
Operating margin
14.7%
Efficiency
Return on assets
10.9%
Return on equity
34.2%
Return on invested capital
20%
Return on capital employed
17.9%
Return on sales
18.4%
Dividend
Dividend yield
0.21%
DPS
$0.2
Payout ratio
6.8%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
0.09%
1 week
-0.35%
1 month
8.63%
1 year
23.25%
YTD
27.84%
QTD
27.84%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$2.96B
Gross profit
$1.51B
Operating income
$436.9M
Net income
$427.2M
Gross margin
51%
Net margin
14.4%
The net income is up by 44% year-on-year and by 34% since the previous quarter
Bruker's net margin has increased by 27% from the previous quarter and by 23% YoY
Bruker's revenue has increased by 17% YoY and by 5% QoQ
BRKR's gross profit is up by 16% year-on-year and by 4.4% since the previous quarter

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
32.17
P/B
9.44
P/S
4.64
EV/EBIT
25.33
EV/EBITDA
20.92
EV/Sales
4.66
BRKR's EPS is up by 46% year-on-year and by 35% since the previous quarter
BRKR's price to earnings (P/E) is 15% lower than its 5-year quarterly average of 37.6 but 2.7% higher than its last 4 quarters average of 31.3
BRKR's equity is up by 24% YoY and by 14% QoQ
The stock's price to book (P/B) is 12% more than its last 4 quarters average of 8.4 and 7% more than its 5-year quarterly average of 8.8
The stock's price to sales (P/S) is 22% more than its last 4 quarters average of 3.8 and 19% more than its 5-year quarterly average of 3.9
Bruker's revenue has increased by 17% YoY and by 5% QoQ

Efficiency

How efficient is Bruker business performance
BRKR's return on assets is up by 28% since the previous quarter and by 28% year-on-year
Bruker's return on equity has increased by 27% QoQ and by 16% YoY
BRKR's return on sales is up by 23% since the previous quarter and by 13% year-on-year
Bruker's return on invested capital has increased by 23% QoQ and by 19% YoY

Dividends

What is BRKR's dividend history
DPS
$0.2
Dividend yield
0.21%
Payout ratio
6.8%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 50% greater than its total liabilities
The quick ratio has decreased by 33% YoY but it has increased by 13% from the previous quarter
BRKR's current ratio is down by 22% year-on-year and by 4.8% since the previous quarter
BRKR's equity is up by 24% YoY and by 14% QoQ
BRKR's debt to equity is down by 13% year-on-year and by 3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.